Longevity Needs a Scientific Sanity Check: Dr Herna de Wit on Evidence, IP and South Africa’s Role in the Future of Healthspan

Supplements, Science and the Longevity Marketing Machine

Supplements promise a lot: mitochondrial support, better brain health, healthier gut function, anti-ageing benefits and more. But how much of that is real science, and how much is simply clever wording on a label? In this episode of Beyond Longevity, Dr Luke Bucci, PhD, Chief Scientific Officer at Juvenon, brings both a scientist’s eye and decades of experience in the supplement industry to one of the most confusing areas of longevity. Dr Luke explains the difference between a product being described as “science-backed” and one that is supported by meaningful human clinical evidence. He also discusses why the dose, form and standardisation of an ingredient matter, and why “fairy-dusting” fashionable ingredients into a formula can make a product sound far more proven than it really is. We talk about bioavailability, absorption, the gut microbiome, and why feeling stimulated is not the same as supporting mitochondrial health. Dr Luke also explains why creatine has moved beyond the gym, why blood flow and nitric oxide matter as we age, and how nutrients such as magnesium, vitamin D3, omega-3s, polyphenols and CoQ10 fit into a more thoughtful approach to supplementation. This is a practical and refreshingly honest conversation about how to read beyond the label, ask better questions, and think more clearly about what supplements can, and cannot, do. Links: Instagram: https://www.instagram.com/juvenonwellness [https://www.instagram.com/juvenonwellness] Facebook: https://www.facebook.com/Juvenon/ [https://www.facebook.com/Juvenon/] Website: https://juvenon.com/ [https://juvenon.com/] 00:00 Welcome and Guest Intro 01:53 Dr Bucci Origin Story 03:26 Science vs Marketing Today 04:44 Science Backed vs Clinical 09:14 Fairy Dusting Exposed 11:05 Bioavailability Reality Check 14:15 Standardisation and Sourcing 22:03 Gut Microbiome Benefits 24:30 Testing and Trial Periods 27:33 Longevity Trend Explained 30:35 Mitochondria 101 34:14 Stimulants vs Real Energy 40:47 Stimulant Band Aid Trap 41:51 Creatine Beyond The Gym 45:08 Creatine Dosing And Safety 47:11 Creatine For Brain Ageing 50:53 Why Blood Flow Declines 53:42 Nitric Oxide Basics 57:44 Arginine Silicate Explained 01:04:45 Polyphenols And Nitrates 01:06:53 My Essential Supplements 01:11:36 Rapid Fire Wisdom 01:13:49 Episode Takeaways

Longevity Needs a Scientific Sanity Check: Dr Herna de Wit on Evidence, IP and South Africa’s Role in the Future of Healthspan

This week on Beyond Longevity, I am joined by Dr Herna de Wit, CEO and Founder of Omnisci Consulting, with a PhD in Biochemistry and an LLB in Law. Dr Herna brings a very unusual and valuable combination to the longevity conversation: deep scientific training, legal expertise and hands-on experience advising companies in the health, biotech and longevity space. Longevity is full of exciting science, but it is also a field where marketing can move faster than evidence. In this episode, we ask a simple but important question: how do we separate what is genuinely credible from what merely sounds convincing? Dr Herna shares her five-point “scientific sanity check” for evaluating longevity products, supplements and protocols. We discuss why human RCT data matters more than animal or cell studies, why dosage and bioavailability are often overlooked, what biological age clocks can and cannot tell us, and why safety, third-party testing, and regulatory discipline are essential in a fast-moving market. We also look at longevity from the perspective of investors and company builders. What are the red flags? What makes a claim scientifically weak? And why does defensible intellectual property matter far beyond simply having a patent? Dr Herna explains how companies can think more intelligently about protectability, including through delivery systems, synergistic formulations, data, know-how and clearer scientific positioning. The conversation then turns to South Africa, a market that many listeners may not immediately associate with longevity, but one that raises fascinating questions. We discuss medical tourism, scientific talent, regulatory realities, affordability and whether South Africa could carve out a distinctive role in the global healthspan conversation. Finally, we speak about one of the most important tensions in longevity: if the science advances, who actually gets access? Is longevity already becoming another layer of privilege, or can the field develop in a way that is more credible, more inclusive and more useful? This is a conversation about evidence, accountability and the future of a field that urgently needs both excitement and discipline. Links: https://www.linkedin.com/in/herna-de-wit-phd-llb/ [https://www.linkedin.com/in/herna-de-wit-phd-llb/] https://linktr.ee/drherna.omnisci [https://linktr.ee/drherna.omnisci] 00:00 Show Intro and Guest 02:41 Dr Herna’s Unusual Path 04:29 What She Does Today 06:13 Five Point Science Audit 11:17 Investor Red Flags 15:31 IP Beyond Patents 20:12 Open Science vs Profit 24:35 Founder IP Strategy 32:54 Global Longevity Hotspots 33:42 South Africa Opportunity 36:33 Access and Inequality 43:12 Regulation and Innovation 46:20 How to Work With Dr Herna 50:02 Rapid Fire Questions 52:20 Final Takeaways Outro

Dr Filippo Ongaro: Space as an Accelerated Ageing Model, Health Span and the Behaviour Gap in Longevity

On Beyond Longevity, Dr Filippo Ongaro, medical doctor, entrepreneur, and strategic advisor, shares how nearly eight years working with astronauts at the European Space Agency shaped the way he thinks about ageing. In space, the body can lose muscle, bone and resilience at a frightening speed. Stress, sleep disruption, nutrition, movement and circadian misalignment are not lifestyle details. They become central medical issues. For Dr Filippo, space became a kind of accelerated ageing model, showing in fast-forward what happens when the systems that keep us strong begin to break down, and why exercise and nutrition are such powerful countermeasures. After leaving ESA, Dr Filippo opened one of Italy’s early anti-ageing and functional medicine centres. But over time, he came to believe that the biggest obstacle in longevity is not simply knowledge, testing, or more biomarkers. It is the behaviour gap. People often know what they should be doing. The harder question is why they do not follow through. Together with his wife Sonya, he shifted from one-to-one clinical work into education, coaching, professional training and strategic advisory, with a focus on making longevity more accessible, affordable and practical, including through pharmacy-based pathways. In this conversation, he argues that longevity should focus on healthspan, avoid overpromising, build trust, start earlier with younger people, and move beyond fear of death towards purpose, identity and the joy of life links: www.metodo-ongaro.com [http://www.metodo-ongaro.com/] https://www.linkedin.com/in/dr-filippo-ongaro/ [https://www.linkedin.com/in/dr-filippo-ongaro/] Dr. Filippo Ongaro [https://www.youtube.com/user/DrFilippoOngaro] 00:00 Welcome and Guest Intro 02:53 From ESA to Longevity 05:07 Space as Accelerated Ageing 07:40 Countermeasures and Behaviour Gap 09:53 Mindset Over Biohacking 14:24 Mission Drives Discipline 17:22 Delayed Gratification Science 20:37 Building Anti-Ageing Practice 22:11 Why People Don't Follow Through 24:31 Who Wanted Anti-Ageing Help 28:16 Pivot to Education at Scale 31:53 Training Health Professionals 32:24 Scaling Impact Through Partners 33:27 Broadening the Audience 34:36 Affordable Longevity Access 37:11 Institutions and Mass Market 40:14 Business Advice for Clinicians 43:26 Hype, Trust, and PR 45:07 Fear Versus Joy of Life 47:16 Identity Driven Change 53:24 Future of Longevity Market 56:00 Healthspan Over Lifespan 57:58 Rapid Fire and Wrap Up 01:00:18 Final Episode Takeaways

Building a Longevity Nation. Reimagining the Second Half of Life with Michael Clinton

Michael A. Clinton, former President of Hearst Magazines. Michael spent four decades at the top of the publishing world, including as President and Publishing Director of Hearst Magazines, before turning his attention to one of the biggest questions of our time. If many of us are likely to live longer than previous generations, how do we make the second half of life not just longer, but more intentional, productive and meaningful? In this episode of Beyond Longevity, Michael discusses the ideas behind his book ROAR and his framework for rethinking later life. ROAR stands for Reimagine, Own your numbers, Action plan and Relationships, and it became the foundation for Roar Forward, his B2B platform advising organisations on the fast-changing 50-plus consumer. The conversation explores why Michael believes we need to shift the language from “ageing” to “longevity”, how culture and business are slowly beginning to respond, and why institutions, employers and policymakers still have a long way to go. Michael also previews ideas from his new book, Longevity Nation, which looks at the people, companies and innovations reshaping what longer lives could mean. He raises important concerns about inequality, access and the growing number of products making claims that are not always backed by evidence. This is also a very personal conversation. Michael reflects on his working-class roots in Pittsburgh, the moment that changed how he thought about identity and reinvention, and why the longest chapter of life may be the one most people have planned for the least. The episode also touches on the economic power of the $8.3 trillion 50-plus consumer, why this market is still widely misunderstood, and the one longevity habit Michael believes anyone can begin with, regardless of income. Links: Longevity Nation [https://www.simonandschuster.com/books/Longevity-Nation/Michael-Clinton/9781582709628] ROAR forward [https://roarforward.com/] LinkedIn [https://www.linkedin.com/in/michael-anthony-clinton/] 00:00 Welcome and Guest Intro 02:19 Early Life and First Memory 03:17 Ambition and Upbringing 05:12 Finding His Career Path 06:29 Hearst Lessons on Identity 09:22 ROAR Framework Explained 13:29 Longevity Economy for Business 16:19 Language and Pro Age Messaging 18:43 Brands and Countries Adapting 21:55 Fear and Reinvention Mindset 22:59 Purposeful Second Act 23:38 Reimagineer Stories 24:37 Why Longevity Nation 27:33 Inequality and Access 30:13 America and 100 Year Life 33:18 Policy Gaps to Fix 35:53 Hope Worries Takeaway 40:16 Rapid Fire Round 42:42 Longevity Habits and Myths 45:05 Closing Reflections

The Promise and Problem of Longevity Testing; Prevention, Access and the Inequality in the field with Niko Hems

What does good prevention actually look like, and is the longevity industry helping people live better, or simply making health feel more complicated? In this episode of Beyond Longevity, Daphna speaks with Niko Hems, Operations Lead at YEARS, a longevity clinic in Berlin, Germany. Niko brings a rare perspective to the conversation. He works inside the longevity field, but he is not afraid to challenge it. He believes deeply in prevention, yet he is sharply aware of where the industry can go wrong, from over-testing and over-promising to fringe science and the uncomfortable gap between those who can afford cutting-edge healthcare and those who are still struggling to access the basics. His own story makes this especially interesting. At 13, Niko became fascinated by nutrition and fitness while trying to gain weight and feel better in his body. Years later, after completing a Master’s in Longevity Sciences and working inside one of Germany’s leading longevity clinics, he put himself through the kinds of tests many people now associate with the future of health, including genome sequencing, microbiome analysis and more than 200 biomarkers. The result was not quite what he expected. Instead of clarity, much of it created anxiety. Instead of answers, it raised a harder question: when does prevention become too much? This is a refreshingly honest conversation about the promises and problems of modern longevity, the tests that help versus the ones that confuse, the basics that still matter most, and what a more credible, useful and accessible version of prevention could look like. Niko Hems Head of Growth at YEARS. Host of Return on Health podcast. Links: https://nikohems.de [https://nikohems.de/] https://www.linkedin.com/in/niko-hems/ [https://www.linkedin.com/in/niko-hems/] https://returnonhealth.de/ [https://returnonhealth.de/] 00:00 Podcast intro and themes 01:52 Nico’s path into longevity 03:37 Defining longevity and healthspan 04:47 Peakspan explained 06:26 Basics that move the needle 08:32 When testing becomes anxiety 10:07 Inside the Years clinic model 14:26 Cost access and inequality 15:58 Who buys high-end programs 17:55 What 16K actually includes 20:43 Why behaviour change is hard 24:07 Are we really getting healthier 26:04 Lifespan hype vs healthspan focus 28:25 Prevention Over Testing 29:23 Affordable Core Diagnostics 30:50 Why Healthcare Lags 32:58 Fixing Incentives 37:37 Longevity Branding Problem 41:09 Basics That Move Needle 43:28 Free High Impact Habits 46:22 AI And Longevity Future 52:04 Rapid Fire Wrap Up 53:42 Final Takeaways